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HepatocyteAbstract Liver transplantation is the only choice for patients with end-stage liver diseases. Hepa-
tocyte transplantation is a promising alternative for treatment of these groups. However, the major
challenge is insufﬁciency of donor organs that can provide good-quality cells. Therefore, numerous
experimental and clinical studies have evaluated the potential of different sources of adult stem
cells, which differentiate into hepatocytes, for cell therapy. Endometrial (stem) stromal cells are
readily isolated and expandable; moreover, these cells have more clonogenicity and pose less tech-
nical problems, so they are considered to possess great autologous therapeutic potential.
We propose that endometrial stem (stromal) cells could be an invaluable and realistic source in
this regard.
ª 2013 Published by Elsevier Ltd. on behalf of Tehran University of Medical Sciences.D license.Introduction
Liver failure is a growing health problem ranking as one of the
supreme causes of death worldwide [1]. Liver transplantation
(LTx) is presently the available efﬁcient method for treatmentof various end-stage liver diseases [2]. However, it is restricted
by the lack of donor organs, immunosuppression and rejection
[3]. Therefore, new therapeutic methods are signiﬁcantly re-
quired. Stem cell-based therapy has been proposed as an alterna-
tiveway to treat liver diseases in an enormous number of patients.n, Iran.
-ND license.
Figure 1 Schematic presentation of our hypothesis.
Human endometrial adult stem cells can be differentiated into hepatocyte cells 31Cell transplantation is less invasive compared to LTx;
it also diminishes mortality in acute liver failure, and
can be employed for the treatment of metabolic liver dis-
eases [4–7].
Hepatocyte transplantation (Htx) has been adopted as the
credible alternative to LTx [2]. Hepatocyte cells have previ-
ously been derived from embryonic stem cells (ESCs), adipose
tissue, bone marrow stem cells, mesenchymal cells and multi-
potent progenitor cells in the human umbilical cord [8–12].
So far, it is not clear as to which stem cell type will be partic-
ularly effective in forming cell lines that will be promising in
cell therapy. Therefore, it seems vital to investigate the capabil-
ity of other sources of adult stem cell such as amniotic stem
cells and endometrial stem cells to prove their potentiality
for medical application.
Human endometrial layers contain a population of
stromal (stem) cells, which are presumed to be adult
stem/progenitor cells that are responsible for the
remarkable regenerative capacity of the endometrium
[13–15].
Human endometrial-derived stem cells (EnSCs) have
the potential to differentiate into mesoderm-derived cells
such as those of chondrogenic and osteoblastic lineages
[16,17].Table 1 Differentiation capacity of endometrial stem/progenitor ce
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In this hypothesis we want to evaluate the potentiality of stem cells whic
* Menstrual blood stem cells have been the only source of derived hepatEnSCs are easily isolated and also expand rapidly from
patients without leading to major ethical and technical prob-
lems, as well as produce a higher overall clonogenicity
[13,18]. Previous studies concerning long-term follow-ups of
animals treated with endometrial regenerative cells with nor-
mal karyotypes, after extended passage (68 doublings), con-
ﬁrmed lack of tumourigenicity of these cells [19]. In
addition, autologous transplantation of endometrial stromal
cells from a healthy donor should minimise the risks of rejec-
tion [20]. Hence, these cells are extremely useful tools for
therapeutic application.
Hypothesis
Multipotent adult stem/progenitor cells in the endometrium
are characterised by a remarkable regenerative capacity of
undergoing repetitive cycles of growth and differentiation.
Endometrial regenerative cells possess the potential to differ-
entiate into adipocytes, endothelial cells, pancreatic cells and
neurons [19] (Table 1). According to our previous invaluable
experiments (un published data), EnSCs have a great poten-
tial to differentiate into adipocytes, osteoblasts as well as
neurons, and these cells are capable of generating odonto-
blasts as well as myoblast cells [21,22]. Thus, it is hypothe-
sised that endometrial adult stem (stromal) cells, could be
novel candidates for derivation of hepatocytes, and provide
an attractive alternative resource for liver cell-based therapies
(Fig. 1).
Evaluation of hypothesis
To conﬁrm our hypotheses:
The biopsies are treated with collagenase for cell isolation.
The isolated cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM). Flow cytometry is preformed for cell-sur-
face markers (CD 146, CD31, CD44, CD90, CD105, CD34,
CD133 and STRO-1) to characterise EnSCs which were iso-
lated from endometrial biopsies. Consequently, after differen-
tiation of the EnSCs into hepatocytes by using speciﬁc
mediums, immunocytochemical procedures are preformed for
evaluating expression of Oct4 and Sox2, and reverse transcrip-
tase polymerase chain reaction (RT-PCR) is performed tolls.
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32 F. Khademi et al.assess the expression of a set of hepatocyte genes such as albu-
min, alpha- fetoprotein and cytokeratin [18]. In addition to
these procedures, some functional studies such as urea synthe-
sis, glycogen storage and indocyanine green (ICG) uptake are
required to assess the hypothesis. Furthermore, in vivo studies
are required to evaluate the potentiality of isolated ESCs. To
do so, the ﬁrst step is to prepare a rat model with persistent li-
ver damage. The second step is to design a plasmid construct
for labelling ESCs. The next step is the transplantation of
the labelled ESCs to the model liver and, ﬁnally, to track the
abilities of the ESCs.
Discussion
Numerous disorders such as Crigler–Najjar syndrome type 1,
glycogen storage disease type I, urea-cycle defects and familial
hypercholesterolaemia are candidates for hepatocyte trans-
plantation [23]. On the other hand, one of the main obstacles
of hepatocyte transplantation is the limited source. All adult
stem cells have the potential to differentiate into hepatocytes,
but to improve the development of cell-based therapies for li-
ver diseases it is necessary to have a sustainable and easily
available source of cells. Endometrium progenitor cells in com-
parison with other sources have great potentiality to expand
and pre-differentiate into distinct cell types. However, other
stem cell sources such as bone marrow and adipose tissue do
not allow for such expansion [19]. Endometrial stromal cells
produce a higher overall clonogenicity of 1.25% in comparison
to the clonogenic activity of stromal cells in bone marrow [18].
Using some sources such as bone marrow has other disadvan-
tages; collecting bone marrow is still an invasive method with
many complications such as infection, bleeding and chronic
pain, thereby limiting the widespread use of bone marrow stro-
mal cells in tissue engineering and cell therapy [20,24].
However, precise in vivo studies are required to evaluate
different aspects of hepatocytes, which are differentiated from
adult stem cells.Conclusion
Among the different sources of adult stem cells, endometrial
stem (stromal) cells propose particularly outstanding beneﬁts
for hepatocyte differentiation:
(a) Even though the populations of endometrial stem (stro-
mal) cells are rare, these cells are readily accessible via
safe and painless procedures.
(b) Autologous transplantation of differentiated cells prob-
ably minimises the risks of rejection.
(c) These cells produced a higher overall clonogenicity;
therefore, they are more suitable for cell therapy.
(d) These cells possess a remarkable ability to differentiate
into different cell types.
(e) These cells are highly expandable in vitro.
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None declared.Overview BoxWhat do we already know about the subject?
Answer: Hepatocytes had formerly been derived from
different adult stem cell sources such as embryonic stem
cells (ESCs), adipose tissue, bone marrow stem cells,
mesenchymal cells and multipotent progenitor cells in
the human umbilical cord. According to our previous
invaluable experiments (unpublished data), human endo-
metrial-derived stem cells (hEnSCs) have great potential
to differentiate into adipocytes, osteoblasts, as well as
neurons. Therefore, it seems requisite to obtain data
about this source before conducting in vivo studies.
What does your proposed theory add to the current knowl-
edge available, and what beneﬁts does it have?
Answer: Among the different sources of adult stem cells,
endometrial stem (stromal) cells propose particularly out-
standing beneﬁts: First, even though the populations of
endometrial stem (stromal) cells are rare, these cells are
readily accessible from donors via a safe and painless pro-
cedure. Second, autologous transplantation of differenti-
ated cells probably minimises the risks of rejection.
Third, these cells produced a higher overall clonogenicity;
therefore, they are more suitable for cell therapy. Finally,
these cells possess remarkable ability to differentiate into
different cell types.
Among numerous available studies, what special further
study is proposed for testing the idea?
Answer: In vivo studies could be performed via different
methods such as:
A primary method; construction of plasmids with repor-
ter genes, stable transfection of the plasmids into endome-
trial stem cells, then injection of these cells into recipient
animals and ﬁnally monitoring the reporter.
The other remarkable experiment which should have been
performed is molecular reprogramming of endometrial
stem cells to hepatocyte-like cells by using deﬁned factors.Acknowledgement
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